NEWLY PUBLISHED in Therapeutic Advances in Psychopharmacology. 2026;16 Read more about NEWLY PUBLISHED in Therapeutic Advances in Psychopharmacology. 2026;16
Glutamate modulation by evenamide produces statistically significant and clinically relevant improvement in patients with TRS Read more about Glutamate modulation by evenamide produces statistically significant and clinically relevant improvement in patients with TRS
Success in the mechanism-based development of evenamide for patients with inadequate response or TRS Read more about Success in the mechanism-based development of evenamide for patients with inadequate response or TRS
Evenamide Phase 3 Program: Study 023 (ENIGMA-TRS 1) evaluates the efficacy of add-on glutamate modulation in patients with documented treatment-resistant schizophrenia Read more about Evenamide Phase 3 Program: Study 023 (ENIGMA-TRS 1) evaluates the efficacy of add-on glutamate modulation in patients with documented treatment-resistant schizophrenia
